CNE1000042Q8
CNE1000042Q8
WUHAN KEQIAN BIOLOGY CO LTD
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 5.78B EUR | 5.64B EUR | 6.77B EUR | 7.11B EUR |
Enterprise Value | 3.14B EUR | 5.48B EUR | 6.58B EUR | 6.94B EUR |
Valuation Multiples | ||||
Trailing P/E | 18.25x | 28.68x | 24.9x | 23.65x |
Forward P/E | 12.41x | -- | -- | -- |
Price to Sales | 6.92x | 9.63x | 9.93x | 10.17x |
Price to Book | 1.42x | 1.4x | 1.57x | 1.68x |
EV/Revenue | 3.75x | 9.35x | 9.65x | 9.93x |
EV/EBITDA | 8.62x | 23.66x | 19.69x | 19.91x |
Price to FCF (P/FCF) | 42.82x | 37.14x | 52.19x | 33.14x |
EV/FCF | 23.22x | 36.07x | 50.7x | 32.35x |
FCF Yield | 2.34% | 2.69% | 1.92% | 3.02% |